404 related articles for article (PubMed ID: 33182039)
21. Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma.
Costa NL; Valadares MC; Souza PP; Mendonça EF; Oliveira JC; Silva TA; Batista AC
Oral Oncol; 2013 Mar; 49(3):216-23. PubMed ID: 23089461
[TBL] [Abstract][Full Text] [Related]
22. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.
Zhang L; Tao L; Shi T; Zhang F; Sheng X; Cao Y; Zheng S; Wang A; Qian W; Jiang L; Lu Y
IUBMB Life; 2015 Oct; 67(10):778-88. PubMed ID: 26452780
[TBL] [Abstract][Full Text] [Related]
23. Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity.
Castro F; Pinto ML; Silva AM; Pereira CL; Teixeira GQ; Gomez-Lazaro M; Santos SG; Barbosa MA; Gonçalves RM; Oliveira MJ
Acta Biomater; 2017 Nov; 63():96-109. PubMed ID: 28919508
[TBL] [Abstract][Full Text] [Related]
24. Tumor-promoting effect of IL-23 in mammary cancer mediated by infiltration of M2 macrophages and neutrophils in tumor microenvironment.
Nie W; Yu T; Sang Y; Gao X
Biochem Biophys Res Commun; 2017 Jan; 482(4):1400-1406. PubMed ID: 27956175
[TBL] [Abstract][Full Text] [Related]
25. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
26. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
[TBL] [Abstract][Full Text] [Related]
27. Melanoma-induced immunosuppression and its neutralization.
Umansky V; Sevko A
Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology.
Voronov E; Apte RN
Curr Pharm Des; 2017; 23(32):4893-4905. PubMed ID: 28606052
[TBL] [Abstract][Full Text] [Related]
29. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
Xu W; Dong J; Zheng Y; Zhou J; Yuan Y; Ta HM; Miller HE; Olson M; Rajasekaran K; Ernstoff MS; Wang D; Malarkannan S; Wang L
Cancer Immunol Res; 2019 Sep; 7(9):1497-1510. PubMed ID: 31340983
[TBL] [Abstract][Full Text] [Related]
30. [The immunosuppressive microenvironment of malignant gliomas].
Borisov KE; Sakaeva DD
Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
[TBL] [Abstract][Full Text] [Related]
31. Overcoming tumor-mediated immunosuppression.
Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
[TBL] [Abstract][Full Text] [Related]
32. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
[TBL] [Abstract][Full Text] [Related]
33. Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape.
Wen Q; Han T; Wang Z; Jiang S
Oncol Lett; 2020 Apr; 19(4):2595-2601. PubMed ID: 32218809
[TBL] [Abstract][Full Text] [Related]
34. Tumor-released autophagosomes induces CD4
Chen YQ; Li PC; Pan N; Gao R; Wen ZF; Zhang TY; Huang F; Wu FY; Ou XL; Zhang JP; Zhu XJ; Hu HM; Chen K; Cai YL; Wang LX
J Immunother Cancer; 2019 Jul; 7(1):178. PubMed ID: 31300052
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
[TBL] [Abstract][Full Text] [Related]
36. The metastasis-promoting roles of tumor-associated immune cells.
Smith HA; Kang Y
J Mol Med (Berl); 2013 Apr; 91(4):411-29. PubMed ID: 23515621
[TBL] [Abstract][Full Text] [Related]
37. Systems-Level Proteomics Evaluation of Microglia Response to Tumor-Supportive Anti-Inflammatory Cytokines.
Ahuja S; Lazar IM
Front Immunol; 2021; 12():646043. PubMed ID: 34566949
[TBL] [Abstract][Full Text] [Related]
38. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity.
Padoan A; Plebani M; Basso D
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764482
[TBL] [Abstract][Full Text] [Related]
39. Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.
Atretkhany KN; Drutskaya MS
Biochemistry (Mosc); 2016 Nov; 81(11):1274-1283. PubMed ID: 27914453
[TBL] [Abstract][Full Text] [Related]
40. Radiation as an immune modulator.
Burnette B; Weichselbaum RR
Semin Radiat Oncol; 2013 Oct; 23(4):273-80. PubMed ID: 24012341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
